Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

CMPS

Compass Pathways Plc ADR

Last Close
Apr 18 • 10:08AM ET
8.60
Dollar change
+0.07
Percentage change
0.88 		%
Scroll to Statements
Index- P/E- EPS (ttm)-2.39 Insider Own8.94% Shs Outstand61.94M Perf Week-6.26%
Market Cap532.99M Forward P/E- EPS next Y-2.22 Insider Trans-15.52% Shs Float56.40M Perf Month-9.71%
Income-118.86M PEG- EPS next Q-0.48 Inst Own33.72% Short Float5.55% Perf Quarter5.84%
Sales0.00M P/S- EPS this Y1.50% Inst Trans1.68% Short Ratio4.34 Perf Half Y37.90%
Book/sh3.64 P/B2.36 EPS next Y2.91% ROA-50.23% Short Interest3.13M Perf Year-13.26%
Cash/sh3.56 P/C2.42 EPS next 5Y3.40% ROE-58.41% 52W Range5.01 - 12.75 Perf YTD-1.66%
Dividend Est.- P/FCF- EPS past 5Y- ROI-46.36% 52W High-32.51% Beta2.39
Dividend TTM- Quick Ratio13.33 Sales past 5Y0.00% Gross Margin- 52W Low71.76% ATR (14)0.64
Dividend Ex-Date- Current Ratio13.33 EPS Y/Y TTM-11.30% Oper. Margin0.00% RSI (14)41.44 Volatility6.26% 6.72%
Employees186 Debt/Eq0.15 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price41.25
Option/ShortYes / Yes LT Debt/Eq0.14 EPS Q/Q27.54% Payout- Rel Volume0.35 Prev Close8.53
Sales Surprise- EPS Surprise-46.65% Sales Q/Q- EarningsFeb 29 BMO Avg Volume721.47K Price8.60
SMA20-6.79% SMA50-14.61% SMA2001.23% Trades Volume35,636 Change0.88%
Date Action Analyst Rating Change Price Target Change
Apr-01-24Initiated Morgan Stanley Overweight $30
Dec-12-23Initiated Deutsche Bank Buy $16
Nov-21-22Resumed Berenberg Buy $33
Nov-01-22Initiated Loop Capital Buy $34
Oct-29-21Initiated Oppenheimer Outperform $50
Jul-13-21Initiated Citigroup Buy $67
Jun-28-21Initiated Maxim Group Buy $70
May-11-21Initiated Cantor Fitzgerald Overweight $71
Apr-01-21Initiated ROTH Capital Buy $88
Oct-14-20Initiated H.C. Wainwright Buy $65
Show Previous Ratings
Apr-01-24 04:01PM
Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference
(GlobeNewswire) +16.35%
Mar-31-24 05:47PM
20 Most Depressed Countries in Asia
(Insider Monkey)
Mar-28-24 08:00AM
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
(GlobeNewswire) -12.42%
Mar-19-24 08:00AM
The Next Great Biotech Boom Has Arrived
(PR Newswire)
Mar-10-24 10:00AM
10 Alternatives to Antidepressant Medications
(Insider Monkey)
09:59AM Loading…
Mar-05-24 09:59AM
15 Highest Paying Jobs with a Psychology Degree
(Insider Monkey) -5.48%
08:52AM
20 Countries with Most Antidepressant Users in the World
(Insider Monkey)
Mar-01-24 09:08AM
COMPASS Pathways plc (NASDAQ:CMPS) Q4 2023 Earnings Call Transcript
(Insider Monkey) +11.78%
Feb-29-24 03:30PM
Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript
(Motley Fool) -16.98%
07:34AM
Compass Pathways PLC Reports Increased Annual Net Loss Amid Clinical Advancements
(GuruFocus.com)
07:00AM
Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights
(GlobeNewswire)
Feb-27-24 12:33PM
Penny Power Players: 3 Stocks to Watch in the Microcap Arena
(InvestorPlace) +9.64%
Feb-26-24 04:01PM
Compass Pathways to participate in upcoming TD Cowen investor conference
(GlobeNewswire)
Feb-22-24 04:01PM
Compass Pathways to announce fourth quarter and year-end 2023 financial results on February 29, 2024
(GlobeNewswire)
Feb-21-24 03:06PM
Mental Health Mavericks: 3 Stocks Changing the Game
(InvestorPlace)
07:00AM Loading…
Feb-19-24 07:00AM
Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.
(Motley Fool)
Feb-02-24 04:27PM
As investors pile into psychedelics, idealism gives way to pharma economics
(Associated Press Finance)
Jan-31-24 04:01PM
Compass Pathways to participate in upcoming Oppenheimer investor conference
(GlobeNewswire)
Jan-24-24 09:00AM
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition
(PR Newswire) +7.87%
Jan-16-24 08:00AM
Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved
(GlobeNewswire)
Jan-09-24 01:56PM
Therapys New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution
(InvestorPlace)
Jan-08-24 11:47AM
3 Big New Catalysts for Psychedelics Stocks in 2024
(Motley Fool) +11.07%
Jan-05-24 08:00AM
Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement
(GlobeNewswire) -6.97%
Dec-29-23 08:42AM
5 Best Psychedelic Stocks to Buy
(Insider Monkey)
Dec-19-23 04:05PM
Compass Pathways announces investigational COMP360 psilocybin treatment was well-tolerated in phase 2 study of post-traumatic stress disorder
(GlobeNewswire)
Dec-13-23 02:55PM
25 Best Online Psychology Degree Programs Heading Into 2024
(Insider Monkey) -6.62%
Dec-07-23 07:00AM
Compass Pathways appoints Teri Loxam as Chief Financial Officer
(GlobeNewswire) +7.94%
Dec-06-23 04:00PM
Study results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry
(GlobeNewswire)
Dec-05-23 04:09PM
Investing in Mental Health: 3 Stocks in the Wellness Space
(InvestorPlace) -7.38%
Nov-24-23 08:00AM
Compass Pathways to participate in upcoming Evercore investor conference
(GlobeNewswire) +6.61%
04:00AM Loading…
Nov-15-23 04:00AM
Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research center
(GlobeNewswire)
Nov-05-23 11:26AM
COMPASS Pathways plc (NASDAQ:CMPS) Q3 2023 Earnings Call Transcript
(Insider Monkey)
Nov-03-23 11:39AM
Compass Pathways Plc (CMPS) Q3 2023 Earnings Call Transcript
(Motley Fool) +7.73%
Nov-02-23 08:51AM
Compass Pathways PLC (CMPS) Reports Q3 2023 Financial Results and Business Highlights
(GuruFocus.com)
07:00AM
COMPASS Pathways Announces Third Quarter 2023 Financial Results and Business Highlights
(GlobeNewswire)
Oct-29-23 05:17PM
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
(Market Exclusive)
Oct-26-23 08:00AM
COMPASS Pathways announces CFO transition
(GlobeNewswire)
Oct-24-23 04:01PM
COMPASS Pathways plc to Announce Third Quarter 2023 Financial Results on November 2, 2023
(GlobeNewswire) +6.86%
Oct-12-23 09:15AM
The Promise Of Psilocybin When It Comes To Mental Health, And How COMPASS Pathways (NASDAQ: CMPS) Is Advancing It
(News Direct)
Oct-06-23 09:00AM
COMPASS Pathways Is Accelerating Patient Access To Evidence-Based Innovation In Mental Health Care
(News Direct)
Sep-27-23 03:17PM
Dont Miss the Boom: 3 Psychedelic Stocks Set to Explode Higher
(InvestorPlace)
Sep-22-23 08:30AM
How COMPASS Pathways Is Leveraging AI To Revolutionize The Mental Healthcare Space
(News Direct)
Sep-19-23 09:25AM
One Year Into Kabir Naths Leadership, Compass Pathways (NASDAQ: CMPS) Phase 3 Trial For Innovative Treatment Resistant Depression Progressing
(News Direct)
Sep-18-23 04:31PM
COMPASS Pathways appoints Daphne Karydas to its Board of Directors
(GlobeNewswire)
Sep-13-23 09:00AM
Whats Spurring The Growth Of The Psychedelics Market And How One Company Is Helping As Part Of The Vanguard In This Emerging Field
(News Direct)
Sep-06-23 04:00AM
COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression
(GlobeNewswire)
Aug-29-23 04:30PM
COMPASS Pathways to participate in upcoming September investor conferences
(GlobeNewswire)
Aug-26-23 07:50AM
3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street
(Motley Fool)
Aug-21-23 07:00AM
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
(Market Exclusive) +11.23%
Aug-16-23 08:58AM
COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors
(GlobeNewswire) +18.46%
Aug-04-23 12:00AM
Compass Pathways Plc (CMPS) Q2 2023 Earnings Call Transcript
(Motley Fool) -5.01%
Aug-03-23 07:00AM
COMPASS Pathways Announces Second Quarter 2023 Financial Results and Business Highlights
(GlobeNewswire)
Jul-31-23 08:32AM
COMPASS Pathways plc to announce second quarter 2023 financial results on August 3, 2023
(GlobeNewswire)
Jul-28-23 10:15AM
This Unexpected Development Is Yet Another Green Flag for Compass Pathways Stock
(Motley Fool)
Jul-25-23 04:00AM
First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine
(GlobeNewswire)
Jul-17-23 04:00AM
COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology
(GlobeNewswire)
Jul-13-23 04:00AM
Opinion paper calls for clarity on the definition of psychedelic-assisted therapy using psilocybin
(GlobeNewswire) +5.19%
Jul-06-23 09:40AM
Its Really a Brain Chemistry Issue: Elon Musk Embraces Ketamine in the Battle Against Depression Here Are 2 Psychedelic Stocks That Analysts Like
(TipRanks)
07:00AM
American Medical Association Releases Language of First New Current Procedural Terminology Code for Psychedelic Therapies
(GlobeNewswire)
Jul-05-23 07:00AM
COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital
(GlobeNewswire)
Jul-01-23 10:04AM
Can Compass Pathways' Stock Gain 458% Like Wall Street Is Expecting?
(Motley Fool)
Jun-29-23 08:00AM
The 3 Best Psychedelic Stocks to Buy Now
(InvestorPlace)
Jun-16-23 07:00AM
COMPASS Pathways to participate in upcoming Cantor Fitzgerald and HC Wainwright investor conferences
(GlobeNewswire)
Jun-06-23 08:00AM
COMPASS Pathways' key patents upheld by the US Patent and Trademark Office
(GlobeNewswire) +9.76%
May-31-23 08:30AM
COMPASS Pathways Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation Officer
(GlobeNewswire)
May-26-23 04:00PM
COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference
(GlobeNewswire)
07:00AM
Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023
(GlobeNewswire)
May-11-23 12:30PM
Compass Pathways Plc (CMPS) Q1 2023 Earnings Call Transcript
(Motley Fool)
07:00AM
COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights
(GlobeNewswire)
May-06-23 09:37AM
This Regulatory Change Means Psychedelic Stocks Are One Step Closer to Being a Buy. Here's Why
(Motley Fool)
May-03-23 04:01PM
COMPASS Pathways plc to announce first quarter 2023 financial results on 11 May 2023
(GlobeNewswire)
May-02-23 07:00AM
American Medical Association to Issue First New Code for Psychedelic Therapies
(GlobeNewswire)
Apr-20-23 08:55AM
After Falling 60% in 1 Year, Is Atai Life Sciences Stock Still a Buy?
(Motley Fool)
Apr-10-23 10:10AM
COMPASS Pathways to participate in upcoming 22nd Annual Needham Virtual Healthcare Conference
(GlobeNewswire)
Mar-12-23 12:22PM
10 Best Psychedelic Stocks to Buy According to Hedge Funds
(Insider Monkey)
Mar-06-23 08:50AM
2 Potentially Explosive Growth Stocks Down 30% or More to Buy for the Next Bull Market
(Motley Fool)
08:30AM
2 Growth Stocks With Incredible Potential in the Next 5 Years
(Motley Fool)
Mar-02-23 10:23AM
COMPASS Pathways to participate in upcoming Cowen 43rd Annual Health Care Conference, Oppenheimer 33rd Annual Healthcare Conference, and Loop Capital Investor Conference
(GlobeNewswire) +5.17%
07:07AM
COMPASS Pathways plc (NASDAQ:CMPS) Q4 2022 Earnings Call Transcript
(Insider Monkey)
12:00AM
Anorexia is the deadliest psychiatric disorder. Could psychedelics help?
(Financial Times)
Mar-01-23 12:12AM
Q4 2022 Compass Pathways PLC Earnings Call
(Thomson Reuters StreetEvents)
Feb-28-23 02:00PM
Compass Pathways Plc (CMPS) Q4 2022 Earnings Call Transcript
(Motley Fool)
07:00AM
COMPASS Pathways Announces Fourth Quarter and Year-End 2022 Financial Results and Business Highlights
(GlobeNewswire)
Feb-24-23 12:01PM
COMPASS Pathways plc to announce fourth quarter and year-end 2022 financial results on 28 February 2023
(GlobeNewswire)
Feb-12-23 02:21PM
7 Long-Term Stocks to Buy With Your Tax Refund
(InvestorPlace)
Feb-07-23 05:52AM
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
(Motley Fool)
Feb-06-23 08:28PM
7 Tempting Sin Stocks to Buy for Promising Profits
(InvestorPlace)
Feb-05-23 02:30PM
The 7 Most Promising Psychedelic Stocks to Buy in February
(InvestorPlace)
Jan-27-23 09:40AM
Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?
(Zacks)
Jan-13-23 12:00PM
All You Need to Know About COMPASS Pathways PLC Sponsored ADR (CMPS) Rating Upgrade to Strong Buy
(Zacks)
Jan-11-23 09:40AM
Are Medical Stocks Lagging COMPASS Pathways (CMPS) This Year?
(Zacks) +5.69%
Dec-08-22 04:00AM
COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP
(GlobeNewswire) -7.24%
Nov-29-22 10:00AM
3 Big Trends Shaking Up Psychedelic Stocks
(Motley Fool)
Nov-28-22 04:01PM
COMPASS Pathways to participate in upcoming Evercore ISI HealthCONx Conference
(GlobeNewswire) -6.07%
Nov-04-22 12:16PM
REFILE-Magic mushroom compound shows promise as depression treatment in key study
(Reuters)
Nov-03-22 01:00PM
COMPASS Pathways plc (CMPS) Q3 2022 Earnings Call Transcript
(Motley Fool)
07:00AM
COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights
(GlobeNewswire)
06:00AM
COMPASS Pathways announces publication of phase 2b study of COMP360 psilocybin therapy for treatment-resistant depression in The New England Journal of Medicine
(GlobeNewswire)
Nov-02-22 05:10PM
Magic mushrooms study finds significant effect on depression
(Financial Times) -7.98%
05:00PM
REFILE-Magic mushroom compound shows promise as depression treatment in key study
(Reuters)
Compass Pathways Plc is an investment holding company. It operates through its subsidiaries which provide mental health care services. The company was founded by Goldsmith George Jay and Malievaskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Malievskaia Ekaterina10% OwnerApr 01 '24Sale8.9625,750230,6664,010,404Apr 02 04:22 PM
Malievskaia Ekaterina10% OwnerApr 01 '24Sale8.9625,750230,6664,008,130Apr 02 04:22 PM
Goldsmith George Jay10% OwnerApr 01 '24Sale8.9625,750230,6664,008,130Apr 02 04:23 PM
Goldsmith George Jay10% OwnerApr 01 '24Sale8.9625,750230,6664,010,404Apr 02 04:23 PM
Malievskaia Ekaterina10% OwnerMar 28 '24Sale8.6525,750222,7764,036,154Apr 01 08:55 AM
Malievskaia Ekaterina10% OwnerMar 28 '24Sale8.6525,750222,7764,033,880Apr 01 08:55 AM
Goldsmith George Jay10% OwnerMar 28 '24Sale8.6525,750222,7764,033,880Apr 01 08:55 AM
Goldsmith George Jay10% OwnerMar 28 '24Sale8.6525,750222,7764,036,154Apr 01 08:55 AM
Malievskaia EkaterinaDirectorMar 13 '24Sale10.8017,203185,8774,061,904Mar 14 09:08 PM
Malievskaia EkaterinaDirectorMar 13 '24Sale10.8017,203185,8774,059,630Mar 14 09:08 PM
Goldsmith George JayDirectorMar 13 '24Sale10.8017,203185,8774,059,630Mar 14 09:12 PM
Goldsmith George JayDirectorMar 13 '24Sale10.8017,203185,8774,061,904Mar 14 09:12 PM
Goldsmith George JayDirectorMar 12 '24Sale10.5815,740166,5344,076,833Mar 14 09:12 PM
Goldsmith George JayDirectorMar 12 '24Sale10.5815,740166,5344,079,107Mar 14 09:12 PM
Malievskaia EkaterinaDirectorMar 12 '24Sale10.5815,740166,5344,079,107Mar 14 09:08 PM
Malievskaia EkaterinaDirectorMar 12 '24Sale10.5815,740166,5344,076,833Mar 14 09:08 PM
Malievskaia EkaterinaDirectorFeb 26 '24Sale10.4517,765185,6024,094,847Feb 27 05:33 PM
Malievskaia EkaterinaDirectorFeb 26 '24Sale10.4517,765185,6024,092,573Feb 27 05:33 PM
Goldsmith George JayDirectorFeb 26 '24Sale10.4517,765185,6024,092,573Feb 27 05:29 PM
Goldsmith George JayDirectorFeb 26 '24Sale10.4517,765185,6024,094,847Feb 27 05:29 PM
Goldsmith George JayDirectorFeb 23 '24Sale10.0611,863119,3354,112,612Feb 27 05:29 PM
Malievskaia EkaterinaDirectorFeb 23 '24Sale10.0611,863119,3354,112,612Feb 27 05:33 PM
Malievskaia EkaterinaDirectorFeb 23 '24Sale10.0611,862119,3254,110,338Feb 27 05:33 PM
Goldsmith George JayDirectorFeb 23 '24Sale10.0611,862119,3254,110,338Feb 27 05:29 PM
Malievskaia EkaterinaDirectorFeb 07 '24Sale10.5622,794240,7534,124,475Feb 08 04:52 PM
Malievskaia EkaterinaDirectorFeb 07 '24Sale10.5622,794240,7534,122,200Feb 08 04:52 PM
Goldsmith George JayDirectorFeb 07 '24Sale10.5622,794240,7534,122,200Feb 08 04:51 PM
Goldsmith George JayDirectorFeb 07 '24Sale10.5622,794240,7534,124,475Feb 08 04:51 PM
Malievskaia EkaterinaDirectorFeb 06 '24Sale10.5919,853210,3154,144,994Feb 08 04:52 PM
Goldsmith George JayDirectorFeb 06 '24Sale10.5919,853210,3154,144,994Feb 08 04:51 PM
Goldsmith George JayDirectorFeb 06 '24Sale10.5919,852210,3044,147,269Feb 08 04:51 PM
Malievskaia EkaterinaDirectorFeb 06 '24Sale10.5919,852210,3044,147,269Feb 08 04:52 PM
Goldsmith George JayDirectorJan 22 '24Sale8.3525,750215,0334,169,745Jan 23 05:54 PM
Goldsmith George JayDirectorJan 22 '24Sale8.3525,750215,0334,172,404Jan 23 05:54 PM
Malievskaia EkaterinaDirectorJan 22 '24Sale8.3525,750215,0334,172,404Jan 23 05:51 PM
Malievskaia EkaterinaDirectorJan 22 '24Sale8.3525,750215,0334,169,745Jan 23 05:51 PM
Malievskaia EkaterinaDirectorJan 19 '24Sale7.9920,206161,4484,195,495Jan 23 05:51 PM
Goldsmith George JayDirectorJan 19 '24Sale7.9920,206161,4484,195,495Jan 23 05:54 PM
Goldsmith George JayDirectorJan 19 '24Sale7.9920,205161,4404,198,154Jan 23 05:54 PM
Malievskaia EkaterinaDirectorJan 19 '24Sale7.9920,205161,4404,198,154Jan 23 05:51 PM
Malievskaia EkaterinaDirectorJan 03 '24Sale8.7421,758190,2264,218,359Jan 04 04:14 PM
Malievskaia EkaterinaDirectorJan 03 '24Sale8.7421,758190,2264,215,701Jan 04 04:14 PM
Goldsmith George JayDirectorJan 03 '24Sale8.7421,758190,2264,215,701Jan 04 04:15 PM
Goldsmith George JayDirectorJan 03 '24Sale8.7421,758190,2264,218,359Jan 04 04:15 PM
Goldsmith George JayDirectorJan 02 '24Sale9.0025,750231,7064,237,459Jan 04 04:15 PM
Goldsmith George JayDirectorJan 02 '24Sale9.0025,750231,7064,240,117Jan 04 04:15 PM
Malievskaia EkaterinaDirectorJan 02 '24Sale9.0025,750231,7064,240,117Jan 04 04:14 PM
Malievskaia EkaterinaDirectorJan 02 '24Sale9.0025,750231,7064,237,459Jan 04 04:14 PM
Goldsmith George JayDirectorDec 14 '23Sale7.811,37710,7534,263,209Dec 15 06:00 PM
Goldsmith George JayDirectorDec 14 '23Sale7.811,37710,7534,265,867Dec 15 06:00 PM
Malievskaia EkaterinaDirectorDec 14 '23Sale7.811,37710,7534,265,867Dec 15 06:02 PM
Malievskaia EkaterinaDirectorDec 14 '23Sale7.811,37710,7534,263,209Dec 15 06:02 PM
Malievskaia EkaterinaDirectorDec 13 '23Sale7.822,85522,3204,267,244Dec 15 06:02 PM
Malievskaia EkaterinaDirectorDec 13 '23Sale7.822,85522,3204,264,586Dec 15 06:02 PM
Goldsmith George JayDirectorDec 13 '23Sale7.822,85522,3204,264,586Dec 15 06:00 PM
Goldsmith George JayDirectorDec 13 '23Sale7.822,85522,3204,267,244Dec 15 06:00 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.